Global epidemiology of haemoglobin disorders and derived service indicators. - Wikidata - awgldk - TriplyDB

Global epidemiology of haemoglobin disorders and derived service indicators.

Global epidemiology of haemoglobin disorders and derived service indicators.

http://www.wikidata.org/entity/Q37108897

about

Hematopoietic stem cell transplantation for people with sickle cell disease Treatment of dental complications in sickle cell disease Conjugate Haemophilus influenzae type b vaccines for sickle cell disease Hydroxyurea for ß-thalassaemia major Treatment of dental complications in sickle cell disease Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia Interventions for treating intrahepatic cholestasis in people with sickle cell disease Interventions for treating leg ulcers in people with sickle cell disease Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease Agents for inhibiting the adhesion of red blood cells to the endothelium in people with sickle cell disease Hematopoietic stem cell transplantation for people with ß-thalassaemia major Magnesium for treating sickle cell disease Deferasirox for managing transfusional iron overload in people with sickle cell disease Conjugate Haemophilus influenzae type b vaccines for sickle cell disease Antibiotics for treating community acquired pneumonia in people with sickle cell disease Interventions for treating intrahepatic cholestasis in people with sickle cell disease Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease Hematopoietic stem cell transplantation for people with sickle cell disease Interventions for treating leg ulcers in people with sickle cell disease Deferasirox for managing iron overload in people with thalassaemia Stem cell transplantation for people with ß thalassaemia major Hematopoietic stem cell transplantation for people with ß-thalassaemia major Deferasirox for managing transfusional iron overload in people with sickle cell disease Interventions for treating leg ulcers in people with sickle cell disease Blood transfusions for treating acute chest syndrome in people with sickle cell disease Blood transfusions for treating acute chest syndrome in people with sickle cell disease Hematopoietic stem cell transplantation for children with sickle cell disease Deferasirox for managing iron overload in people with thalassaemia Deferasirox for managing transfusional iron overload in people with sickle cell disease Hb E/beta-thalassaemia: a common & clinically diverse disorder The distribution of haemoglobin C and its prevalence in newborns in Africa Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review Application of Innovative Hemocytometric Parameters and Algorithms for Improvement of Microcytic Anemia Discrimination Oxidative stress and β-thalassemic erythroid cells behind the molecular defect Epistasis and the sensitivity of phenotypic screens for beta thalassaemia Online biomedical resources for malaria-related red cell disorders The inherited diseases of hemoglobin are an emerging global health burden.Animal models of β-hemoglobinopathies: utility and limitations Endothelin-1 but not Endothelial Nitric Oxide Synthase Gene Polymorphism is Associated with Sickle Cell Disease in Africa

P2860

Q24185759-EB2D87F9-A5C9-40F2-BE5A-58662EBC736B Q24185872-F56DB578-38CC-4464-8D85-307B399DCD42 Q24186131-356B2DDE-E249-4C7A-80A0-EEF97E64B4B3 Q24186644-DEB15EF8-1C26-491A-8AF9-88B488E6916A Q24186941-B54214BF-CA46-4364-976D-882CBD262F3A Q24186957-FAAAE016-1EAB-413D-8740-1A4A5697D209 Q24187279-E4E86005-FB13-4D1B-ABF6-3588EFBB51D4 Q24187407-518C52F6-690C-479A-A706-879D9C0C96E7 Q24187920-10CC7642-883F-41D2-8ADB-14C8EA55F8D2 Q24188211-08C8CDB2-D16E-48CE-BE82-A97C21C58E7F Q24193101-01715453-C671-43D6-AB22-602EE85DEE89 Q24193246-43DAED67-E893-4BBD-84EA-C43CA3A7E5E0 Q24194549-BF7A232F-8832-48D4-87B5-F23BD5284FE1 Q24195046-31D38C5C-73EE-47F8-B0D7-970D9F87CC9D Q24197977-6D61666C-0FEA-489C-9974-64D84260E3E0 Q24200803-E125A681-7E7F-450C-A675-89B0BE0C0794 Q24202057-3FF126AA-6157-4BC7-A1FE-06C0ECD776DF Q24202852-197F42A0-3372-4B4D-9BBA-753E101C54BD Q24202954-D9CD2E2D-0823-481A-A9DB-39F84857C059 Q24203718-6E57657F-2A00-4C69-BEBB-7A02F2CD29F3 Q24235816-F93A62B4-6ACD-46DD-8340-D8C384A17F74 Q24236027-7BFD3C16-FCA0-4713-A6D6-A0EEAE40D365 Q24236463-4451B0D2-50AD-40B9-AEDD-42195B61F9F7 Q24239921-754EEB45-21AC-425D-A1F2-2E55B99C606C Q24240355-17AE9F0A-5D00-4575-973B-CA263F8DF9D5 Q24240450-EB96BF09-FC0B-448C-82F8-35AC21DB0E17 Q24240994-40342EE9-F415-426B-B661-344C176D250A Q24241753-396E0283-3B17-4DD7-878D-7373E49CBC90 Q24242535-086949CB-78CB-4610-9E9F-F0015FEE953E Q24628973-AA3E3EF4-99A8-4E1C-85A2-71AB59F7DF3F Q24633471-66C90954-762C-4D7F-983B-7034D715F950 Q24633916-0C51D8AA-139F-4388-8AB9-547AFA784667 Q26750731-D345CE85-BE13-4F42-9C19-7D9C01DC7E60 Q26786689-92F55308-5DD7-4E1C-B359-239CC155ACE8 Q26995805-68683C7F-302C-4E0E-B681-05F1E8165762 Q27021805-9D6773B7-8D2C-4646-9604-B2915F28DE85 Q27024694-116DAB0D-8AAE-4D5C-BFE3-4724D0898107 Q27686848-0B9601CC-E613-4F11-9D59-80EEA4D741B3 Q28067142-2E0B8653-578E-4089-9ED5-601BD8E5CFCE Q28387609-7034DAFD-217A-49D5-8BAC-13BFBDFE6FC4

P2860

Global epidemiology of haemoglobin disorders and derived service indicators.

http://www.wikidata.org/entity/Q37108897

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Global epidemiology of haemoglobin disorders and derived service indicators.

@en

Global epidemiology of haemoglobin disorders and derived service indicators.

@nl

type

label

Global epidemiology of haemoglobin disorders and derived service indicators.

@en

Global epidemiology of haemoglobin disorders and derived service indicators.

@nl

prefLabel

Global epidemiology of haemoglobin disorders and derived service indicators.

@en

Global epidemiology of haemoglobin disorders and derived service indicators.

@nl

P1433

Q37108897-709FA3B7-9E48-4760-974C-514F6ED897A4

P1476

Q37108897-9C6DC6E5-E3DA-4202-A0AD-86C183554556

P2093

Q37108897-545E1D3D-A1CD-4B00-BCFD-B200C63BB049

Q37108897-A5B122A3-5E36-410C-AF3F-CC6CFC08055E

P2860

Q37108897-0BB1D816-8322-49C0-B467-1632EDC5F81B

Q37108897-25C9394D-4954-4691-9F6D-8D675A1F247A

Q37108897-2BCDE4E9-BA31-4261-8C69-6DA5F2F73B78

Q37108897-3739DD61-BC91-43E5-9884-83E4F355147E

Q37108897-37BEDFE3-6779-4A7F-8D6C-3CB1368BC7FB

Q37108897-40CE8A77-1280-4911-B2EE-724E10CFDA29

Q37108897-4CDE573B-55CB-4348-A2BA-C47802D94ACF

Q37108897-5AB4DB83-36BF-4F03-BD99-761B8DBD63BC

Q37108897-5BA1F5CE-C89C-404E-AC19-BA392EB79BB9

Q37108897-6849400C-E609-4124-BF19-2B2CE7AE63F4

P304

Q37108897-F96F2479-F15D-4912-BDE0-3BFFCBBF3E7D

P31

Q37108897-034C20B5-9743-4EDC-B5D3-678D691B9DF3

P356

Q37108897-FF9ED4FA-87FC-456C-ADB7-74E0D4179D51

P407

Q37108897-2BEC49F2-CECE-4F01-8DBB-B6480C0F33B3

P433

Q37108897-90D8A3FC-C07C-4AF7-9A8E-AF7704ADDA4A

P478

Q37108897-F38874D1-4B79-4DFD-9ED3-B16CD2D4220D

P50

Q37108897-E00A1289-0EDF-47B8-A59E-CE12CCE2534A

P577

Q37108897-24A88FEE-A8A5-4D27-BF44-BC63F65ACA00

P5875

Q37108897-AAB0736E-6F75-48C0-AB56-61663CCA25FB

P698

Q37108897-079ACA00-F317-4401-8E03-DE1E002ECC03

P921

Q37108897-CAA87EEE-E654-4799-99CA-DCC192AA74D1

P932

Q37108897-53C160BC-9A29-4ED3-BF50-D179B6E54DA7

P356

P1433

Bulletin of the World Health Organization

P1476

Global epidemiology of haemoglobin disorders and derived service indicators.

@en

P2093

Bernadette Modell

http://www.w3.org/2001/XMLSchema#string

Matthew Darlison

http://www.w3.org/2001/XMLSchema#string

P2860

Iranian national thalassaemia screening programme

Inherited haemoglobin disorders: an increasing global health problem

Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume

The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?

Long-term effect of prospective detection of high genetic risk on couples' reproductive life: data for thalassaemia.

Molecular basis of beta-thalassemia in the Maldives.

Hereditary anaemias in Portugal: epidemiology, public health significance, and control.

Role of deferiprone in chelation therapy for transfusional iron overload.

Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia.

Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools

P304

480-487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2471/BLT.06.036673

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Bernadette Modell

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5286864

http://www.w3.org/2001/XMLSchema#string

P698

18568278

http://www.w3.org/2001/XMLSchema#string

P921

P932

2647473

http://www.w3.org/2001/XMLSchema#string